Publications

  1. Kohorst MA, Warad DM, Matsumoto JM, Heimbach JK, El-Youssef M, Arndt CAS, Rodriguez V, Nageswara Rao AA. Management of pediatric hepatocellular carcinoma: A multimodal approach. Pediatr Transplant 2017 Jun 20 Epub 2017 June 20
    View PubMed
  2. Han S, Yang JD, Sinn DH, Kim JM, Choi GS, Jung G, Ahn JH, Kim S, Ko JS, Gwak MS, Kwon CHD, Leise MD, Gwak GY, Heimbach JK, Kim GS. Risk of Post-transplant Hepatocellular Carcinoma Recurrence Is Higher in Recipients of Livers From Male Than Female Living Donors. Ann Surg 2017 Jun 16 Epub 2017 June 16
    View PubMed
  3. Ramanan P, Cummins NW, Wilhelm MP, Heimbach JK, Dierkhising R, Kremers WK, Rosen CB, Gores GJ, Razonable RR. Epidemiology, Risk Factors and Outcomes of Infections in Patients undergoing Liver Transplantation for Hilar Cholangiocarcinoma. Clin Transplant 2017 Jun 02 Epub 2017 June 02
    View PubMed
  4. Yang JD, Larson JJ, Watt KD, Allen AM, Wiesner RH, Gores GJ, Roberts LR, Heimbach JA, Leise MD. Hepatocellular Carcinoma Is the Most Common Indication for Liver Transplantation and Placement on the Waitlist in the United States. Clin Gastroenterol Hepatol 2017 May; 15 (5):767-775.e3 Epub 2016 Dec 21
    View PubMed
  5. Goldberg DS, Karp SJ, McCauley ME, Markmann JF, Croome KP, Taner CB, Heimbach JK, Leise MD, Fryer JP, Bohorquez HE, Cohen AJ, Gilroy RK, Kumer SC, Foley DP, Karim AS, Hernandez-Alejandro R, Levstik MA, Abt PL. Interpreting Outcomes in DCDD Liver Transplantation: First Report of the Multicenter IDOL Consortium. Transplantation 2017 May; 101 (5):1067-1073
    View PubMed
  6. Miller CM, Quintini C, Dhawan A, Durand F, Heimbach JK, Kim-Schluger HL, Kyrana E, Lee SG, Lerut J, Lo CM, Pomfret EA. The International Liver Transplantation Society Living Donor Liver Transplant Recipient Guideline. Transplantation 2017 May; 101 (5):938-944
    View PubMed
  7. Mehta N, Heimbach J, Harnois DM, Sapisochin G, Dodge JL, Lee D, Burns JM, Sanchez W, Greig PD, Grant DR, Roberts JP, Yao FY. Validation of a Risk Estimation of Tumor Recurrence After Transplant (RETREAT) Score for Hepatocellular Carcinoma Recurrence After Liver Transplant. JAMA Oncol 2017 Apr 01; 3 (4):493-500
    View PubMed
  8. Mehta N, Heimbach J, Lee D, Dodge JL, Harnois D, Burns J, Sanchez W, Roberts JP, Yao FY. Wait Time of < 6 and > 18 Months Predicts Hepatocellular Carcinoma Recurrence after Liver Transplantation: Proposing a Wait Time "Sweet Spot". Transplantation 2017 Mar 28 [Epub ahead of print]
    View PubMed
  9. Mouchli MA, Singh S, Loftus EV Jr, Boardman L, Talwalkar J, Rosen CB, Heimbach JK, Wiesner RH, Hasan B, Poterucha JJ, Watt KD. Risk Factors and Outcomes of De novo Cancers (Excluding Nonmelanoma Skin Cancer) after Liver Transplantation for Primary Sclerosing Cholangitis. Transplantation 2017 Mar 08 [Epub ahead of print]
    View PubMed
  10. Nicolas CT, Nyberg SL, Heimbach JK, Watt K, Chen HS, Hathcock MA, Kremers WK. Liver transplantation after share 35: Impact on pretransplant and posttransplant costs and mortality. Liver Transpl 2017 Jan; 23 (1):11-18 Epub 2016 Dec 05
    View PubMed
  11. DeMartino ES, Cartin-Ceba R, Findlay JY, Heimbach JK, Krowka MJ. Frequency and Outcomes of Patients With Increased Mean Pulmonary Artery Pressure at the Time of Liver Transplantation. Transplantation 2017 Jan; 101 (1):101-106
    View PubMed
  12. Nicolas CT, Nyberg SL, Heimbach JK, Watt K, Chen HS, Hathcock MA, Kremers WK. Liver transplantation after share 35: Impact on pretransplant and posttransplant costs and mortality Liver Transplantation 2017; 23 (1):11-8
  13. Miller CM, Quintini C, Dhawan A, Durand F, Heimbach JK, Kim-Schluger L, Kyrana E, Lee SG, Lerut J, Lo CM, Pomfret EA. The International Liver Transplant Society (ILTS) Living Donor Liver Transplant Recipient Guideline. Transplantation 2016 Dec 06 [Epub ahead of print]
    View PubMed
  14. Wong TW, Gandhi MJ, Daly RC, Kushwaha SS, Pereira NL, Rosen CB, Stegall MD, Heimbach JK, Taner T. Liver Allograft Provides Immunoprotection for the Cardiac Allograft in Combined Heart-Liver Transplantation. Am J Transplant 2016 Dec; 16 (12):3522-3531 Epub 2016 June 24
    View PubMed
  15. Heimbach J. Surgical advances in obese candidates and recipients. Liver Transpl 2016 Nov; 22 (S1):62-67
    View PubMed
  16. iCCA International Consortium, Sapisochin G, Facciuto M, Rubbia-Brandt L, Marti J, Mehta N, Yao FY, Vibert E, Cherqui D, Grant DR, Hernandez-Alejandro R, Dale CH, Cucchetti A, Pinna A, Hwang S, Lee SG, Agopian VG, Busuttil RW, Rizvi S, Heimbach JK, Montenovo M, Reyes J, Cesaretti M, Soubrane O, Reichman T, Seal J, Kim PT, Klintmalm G, Sposito C, Mazzaferro V, Dutkowski P, Clavien PA, Toso C, Majno P, Kneteman N, Saunders C, Bruix J. Liver transplantation for "very early" intrahepatic cholangiocarcinoma: International retrospective study supporting a prospective assessment. Hepatology 2016 Oct; 64 (4):1178-88 Epub 2016 Aug 24
    View PubMed
  17. Darwish Murad S, Fidler JL, Poterucha JJ, Sanchez W, Jowsey SG, Nagorney D, Rosen CB, Heimbach JK. Longterm clinical and radiological follow-up of living liver donors. Liver Transpl 2016 Jul; 22 (7):934-42
    View PubMed
  18. Krowka MJ, Fallon MB, Kawut SM, Fuhrmann V, Heimbach JK, Ramsay MA, Sitbon O, Sokol RJ. International Liver Transplant Society Practice Guidelines: Diagnosis and Management of Hepatopulmonary Syndrome and Portopulmonary Hypertension. Transplantation 2016 Jul; 100 (7):1440-52
    View PubMed
  19. Sio TT, Martenson JA Jr, Haddock MG, Novotny PJ, Gores GJ, Alberts SR, Miller RC, Heimbach JK, Rosen CB. Outcome of Transplant-fallout Patients With Unresectable Cholangiocarcinoma. Am J Clin Oncol 2016 Jun; 39 (3):271-5
    View PubMed
  20. Harper AM, Edwards E, Washburn WK, Heimbach J. An early look at the Organ Procurement and Transplantation Network explant pathology form data. Liver Transpl 2016 Jun; 22 (6):757-64
    View PubMed
  21. Miller CM, Durand F, Heimbach JK, Kim-Schluger L, Lee SG, Lerut J, Lo CM, Quintini C, Pomfret EA. The International Liver Transplant Society Guideline on Living Liver Donation. Transplantation 2016 Jun; 100 (6):1238-43
    View PubMed
  22. Lehrke HD, Heimbach JK, Wu TT, Jenkins SM, Gores GJ, Rosen CB, Mounajjed T. Prognostic Significance of the Histologic Response of Perihilar Cholangiocarcinoma to Preoperative Neoadjuvant Chemoradiation in Liver Explants. Am J Surg Pathol 2016 Apr; 40 (4):510-8
    View PubMed
  23. Taner T, Heimbach JK, Rosen CB, Nyberg SL, Park WD, Stegall MD. Decreased chronic cellular and antibody-mediated injury in the kidney following simultaneous liver-kidney transplantation. Kidney Int 2016 Apr; 89 (4):909-17 Epub 2016 Jan 23
    View PubMed
  24. Bhat M, Hathcock M, Kremers WK, Darwish Murad S, Schmit G, Martenson J, Alberts S, Rosen CB, Gores GJ, Heimbach J. Portal vein encasement predicts neoadjuvant therapy response in liver transplantation for perihilar cholangiocarcinoma protocol. Transpl Int 2015 Dec; 28 (12):1383-91 Epub 2015 Aug 06
    View PubMed
  25. Mansour JC, Aloia TA, Crane CH, Heimbach JK, Nagino M, Vauthey JN. Hilar cholangiocarcinoma: expert consensus statement. HPB (Oxford) 2015 Aug; 17 (8):691-9
    View PubMed
  26. Croome KP, Rosen CB, Heimbach JK, Nagorney DM. Is Liver Transplantation Appropriate for Patients with Potentially Resectable De Novo Hilar Cholangiocarcinoma? J Am Coll Surg. 2015 Jul; 221(1):130-9. Epub 2015 Mar 11.
    View PubMed
  27. Fussner LA, Heimbach JK, Fan C, Dierkhising R, Coss E, Leise MD, Watt KD. Cardiovascular disease after liver transplantation: When, What, and Who Is at Risk. Liver Transpl 2015 Jul; 21 (7):889-96
    View PubMed
  28. Croome KP, Hernandez-Alejandro R, Parker M, Heimbach J, Rosen C, Nagorney DM. Is the liver kinetic growth rate in ALPPS unprecedented when compared with PVE and living donor liver transplant? A multicentre analysis. HPB (Oxford) 2015 Jun; 17 (6):477-84 Epub 2015 Feb 28
    View PubMed
  29. Heimbach JK, Hirose R, Stock PG, Schladt DP, Xiong H, Liu J, Olthoff KM, Harper A, Snyder JJ, Israni AK, Kasiske BL, Kim WR. Delayed hepatocellular carcinoma model for end-stage liver disease exception score improves disparity in access to liver transplant in the United States. Hepatology 2015 May; 61 (5):1643-50 Epub 2015 Feb 24
    View PubMed
  30. Terzi E, Ray Kim W, Sanchez W, Charlton MR, Schmeltzer P, Gores GJ, Andrews JC, Smyrk TC, Heimbach JK. Impact of multiple transarterial chemoembolization treatments on hepatocellular carcinoma for patients awaiting liver transplantation. Liver Transpl 2015 Feb; 21 (2):248-57
    View PubMed
  31. Barbara DW, Rehfeldt KH, Heimbach JK, Rosen CB, Daly RC, Findlay JY. The perioperative management of patients undergoing combined heart-liver transplantation. Transplantation. 2015 Jan; 99(1):139-44.
    View PubMed
  32. Koning L, Charlton MR, Pas SD, Heimbach JK, Osterhaus AD, Watt KD, Janssen HL, de Knegt RJ, van der Eijk AA. Prevalence and clinical consequences of Hepatitis E in patients who underwent liver transplantation for chronic Hepatitis C in the United States. BMC Infect Dis 2015; 15:371 Epub 2015 Sept 02
    View PubMed
  33. Heimbach J. Debate: A bridge too far--liver transplantation for nonalcoholic steatohepatitis will overwhelm the organ supply. Liver Transpl 2014 Nov; 20 Suppl 2:S32-7
    View PubMed
  34. Tabibian JH, Trussoni CE, O'Hara SP, Splinter PL, Heimbach JK, LaRusso NF. Characterization of cultured cholangiocytes isolated from livers of patients with primary sclerosing cholangitis. Lab Invest 2014 Oct; 94 (10):1126-33 Epub 2014 July 21
    View PubMed
  35. Fussner LA, Charlton MR, Heimbach JK, Fan C, Dierkhising R, Coss E, Watt KD. The impact of gender and NASH on chronic kidney disease before and after liver transplantation. Liver Int. 2014 Sep; 34(8):1259-66. Epub 2013 Nov 21.
    View PubMed
  36. Chedid MF, Rosen CB, Nyberg SL, Heimbach JK. Excellent long-term patient and graft survival are possible with appropriate use of livers from deceased septuagenarian and octogenarian donors. HPB (Oxford). 2014 Sep; 16(9):852-8. Epub 2014 Jan 28.
    View PubMed
  37. Allen AM, Kim WR, Therneau TM, Larson JJ, Heimbach JK, Rule AD. Chronic kidney disease and associated mortality after liver transplantation--a time-dependent analysis using measured glomerular filtration rate. J Hepatol 2014 Aug; 61 (2):286-92 Epub 2014 Apr 05
    View PubMed
  38. Watt KD, Fan C, Therneau T, Heimbach JK, Seaberg EC, Charlton MR. Serum adipokine and inflammatory markers before and after liver transplantation in recipients with major cardiovascular events. Liver Transpl 2014 Jul; 20 (7):791-7 Epub 2014 May 26
    View PubMed
  39. Leise MD, Yun BC, Larson JJ, Benson JT, Yang JD, Therneau TM, Rosen CB, Heimbach JK, Biggins SW, Kim WR. Effect of the pretransplant serum sodium concentration on outcomes following liver transplantation. Liver Transpl 2014 Jun; 20 (6):687-97
    View PubMed
  40. Taner T, Stegall MD, Heimbach JK. Antibody-mediated rejection in liver transplantation: current controversies and future directions. Liver Transpl. 2014 May; 20(5):514-27. Epub 2014 Feb 25.
    View PubMed
  41. Kim DJ, Clark PJ, Heimbach J, Rosen C, Sanchez W, Watt K, Charlton MR. Recurrence of hepatocellular carcinoma: Importance of mRECIST response to chemoembolization and tumor size. Am J Transplant. 2014; 14(6):1383-90.
    View PubMed
  42. Chauhan A, Diwan TS, Franco Palacios CR, Dean PG, Heimbach JK, Chow GK, Prieto M, Cosio FG, Taler SJ, Textor SC, Kudva YC, Cornell LD, Stegall MD. Using implantation biopsies as a surrogate to evaluate selection criteria for living kidney donors. Transplantation. 2013 Dec 15; 96(11):975-80.
    View PubMed
  43. Duarte-Rojo A, Budhraja V, Veldt BJ, Goldstein DD, Watt KD, Heimbach JK, McHutchison JG, Tillman HL, Poterucha JJ, Charlton MR. Interleukin-28B and fibrosing cholestatic hepatitis in posttransplant hepatitis C: a case-control study and literature review. Liver Transpl. 2013 Dec; 19(12):1311-7.
    View PubMed
  44. Heimbach JK. Infrastructure, logistics and regulation of transplantation: UNOS. Anesthesiol Clin. 2013 Dec; 31(4):659-66. Epub 2013 Nov 01.
    View PubMed
  45. Asrani SK, Kim WR, Edwards EB, Larson JJ, Thabut G, Kremers WK, Therneau TM, Heimbach J. Impact of the center on graft failure after liver transplantation. Liver Transpl 2013 Sep; 19 (9):957-64 Epub 2013 July 26
    View PubMed
  46. Watt KD, Dierkhising R, Fan C, Heimbach JK, Tillman H, Goldstein D, Thompson A, Krishnan A, Charlton MR. Investigation of PNPLA3 and IL28B genotypes on diabetes and obesity after liver transplantation: insight into mechanisms of disease. Am J Transplant. 2013 Sep; 13(9):2450-7. Epub 2013 Jul 16.
    View PubMed
  47. Krowka MJ, Wiesner RH, Heimbach JK. Pulmonary contraindications, indications and MELD exceptions for liver transplantation: a contemporary view and look forward. J Hepatol. 2013 Aug; 59(2):367-74. Epub 2013 Apr 01.
    View PubMed
  48. Singal AK, Kamath PS, Francisco Ziller N, DiCecco S, Shoreibah M, Kremers W, Charlton MR, Heimbach JK, Watt KD, Shah VH. Nutritional status of patients with alcoholic cirrhosis undergoing liver transplantation: time trends and impact on survival. Transpl Int 2013 Aug; 26 (8):788-94 Epub 2013 June 11
    View PubMed
  49. Chedid MF, Muthu C, Nyberg SL, Lesnick TG, Kremers WK, Prieto M, Heimbach JK, Chow GK, Stegall MD, Dean PG. Living donor kidney transplantation using laparoscopically procured multiple renal artery kidneys and right kidneys. J Am Coll Surg. 2013 Jul; 217(1):144-52; discussion 152.
    View PubMed
  50. Iyer VN, Swanson KL, Cartin-Ceba R, Dierkhising RA, Rosen CB, Heimbach JK, Wiesner RH, Krowka MJ. Hepatopulmonary syndrome: favorable outcomes in the MELD exception era. Hepatology 2013 Jun; 57 (6):2427-35 Epub 2013 Feb 15
    View PubMed
  51. Darwish Murad S, Heimbach JK, Gores GJ, Rosen CB, Benson JT, Kim WR. Excellent quality of life after liver transplantation for patients with perihilar cholangiocarcinoma who have undergone neoadjuvant chemoradiation. Liver Transpl 2013 May; 19 (5):521-8 Epub 2013 Apr 09
    View PubMed
  52. Findlay JY, Long TR, Joyner MJ, Heimbach JK, Wass CT. Changes in transfusion practice over time in adult patients undergoing liver transplantation. J Cardiothorac Vasc Anesth. 2013 Feb; 27(1):41-5. Epub 2012 Jul 18.
    View PubMed
  53. Heimbach JK, Watt KD, Poterucha JJ, Ziller NF, Cecco SD, Charlton MR, Hay JE, Wiesner RH, Sanchez W, Rosen CB, Swain JM. Combined liver transplantation and gastric sleeve resection for patients with medically complicated obesity and end-stage liver disease. Am J Transplant. 2013 Feb; 13(2):363-8. Epub 2012 Nov 08.
    View PubMed
  54. Kim WR, Stock PG, Smith JM, Heimbach JK, Skeans MA, Edwards EB, Harper AM, Snyder JJ, Israni AK, Kasiske BL. OPTN/SRTR 2011 Annual Data Report: liver. Am J Transplant. 2013 Jan; 13 Suppl 1:73-102.
    View PubMed
  55. Gores GJ, Darwish Murad S, Heimbach JK, Rosen CB. Liver transplantation for perihilar cholangiocarcinoma. Dig Dis. 2013; 31(1):126-9. Epub 2013 Jun 17.
    View PubMed
  56. Asrani SK, Asrani NS, Freese DK, Phillips SD, Warnes CA, Heimbach J, Kamath PS. Congenital heart disease and the liver. Hepatology. 2012 Sep; 56(3):1160-9. Epub 2012 Aug 02.
    View PubMed
  57. Watt KD, Dierkhising R, Heimbach JK, Charlton MR. Impact of sirolimus and tacrolimus on mortality and graft loss in liver transplant recipients with or without hepatitis C virus: an analysis of the Scientific Registry of Transplant Recipients Database. Liver Transpl. 2012 Sep; 18(9):1029-36.
    View PubMed
  58. Darwish Murad S, Kim WR, Therneau T, Gores GJ, Rosen CB, Martenson JA, Alberts SR, Heimbach JK. Predictors of pretransplant dropout and posttransplant recurrence in patients with perihilar cholangiocarcinoma. Hepatology 2012 Sep; 56 (3):972-81 Epub 2012 July 17
    View PubMed
  59. Duarte-Rojo A, Veldt BJ, Goldstein DD, Tillman HL, Watt KD, Heimbach JK, McHutchison JG, Poterucha JJ, Vargas-Vorackova F, Charlton MR. The course of posttransplant hepatitis C infection: comparative impact of donor and recipient source of the favorable IL28B genotype and other variables. Transplantation. 2012 Jul 27; 94(2):197-203.
    View PubMed
  60. Sembera S, Lammert C, Talwalkar JA, Sanderson SO, Poterucha JJ, Hay JE, Wiesner RH, Gores GJ, Rosen CB, Heimbach JK, Charlton MR. Frequency, clinical presentation, and outcomes of drug-induced liver injury after liver transplantation. Liver Transpl 2012 Jul; 18 (7):803-10
    View PubMed
  61. Rosen CB, Darwish Murad, Heimbach JK, Nyberg SL, Nagorney DM, Gores GJ. Neoadjuvant therapy and liver transplantation for hilar cholangiocarcinoma: is pretreatment pathological confirmation of diagnosis necessary? J Am Coll Surg. 2012 Jul; 215(1):31-8; discussion 38-40. Epub 2012 May 22.
    View PubMed
  62. Darwish Murad S, Kim WR, Harnois DM, Douglas DD, Burton J, Kulik LM, Botha JF, Mezrich JD, Chapman WC, Schwartz JJ, Hong JC, Emond JC, Jeon H, Rosen CB, Gores GJ, Heimbach JK. Efficacy of neoadjuvant chemoradiation, followed by liver transplantation, for perihilar cholangiocarcinoma at 12 US centers. Gastroenterology 2012 Jul; 143 (1):88-98.e3; quiz e14 Epub 2012 Apr 12
    View PubMed
  63. Taner T, Gandhi MJ, Sanderson SO, Poterucha CR, De Goey SR, Stegall MD, Heimbach JK. Prevalence, course and impact of HLA donor-specific antibodies in liver transplantation in the first year. Am J Transplant. 2012 Jun; 12(6):1504-10. Epub 2012 Mar 15.
    View PubMed
  64. Levy MJ, Heimbach JK, Gores GJ. Endoscopic ultrasound staging of cholangiocarcinoma. Curr Opin Gastroenterol. 2012 May; 28(3):244-52.
    View PubMed
  65. Veldt BJ, Duarte-Rojo A, Thompson AJ, Watt KD, Heimbach JK, Tillmann HL, Goldstein DD, McHutchison JG, Charlton MR. Recipient IL28B polymorphism is an important independent predictor of posttransplant diabetes mellitus in liver transplant patients with chronic hepatitis C. Am J Transplant. 2012 Mar; 12(3):737-44. Epub 2012 Feb 02.
    View PubMed
  66. Charlton MR, Burns JM, Pedersen RA, Watt KD, Heimbach JK, Dierkhising RA. Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States. Gastroenterology 2011 Oct; 141 (4):1249-53 Epub 2011 July 02
    View PubMed
  67. Ali AH, Koutsari C, Mundi M, Stegall MD, Heimbach JK, Taler SJ, Nygren J, Thorell A, Bogachus LD, Turcotte LP, Bernlohr D, Jensen MD. Free fatty acid storage in human visceral and subcutaneous adipose tissue: role of adipocyte proteins. Diabetes 2011 Sep; 60 (9):2300-7 Epub 2011 Aug 01
    View PubMed
  68. Massoud O, Heimbach J, Viker K, Krishnan A, Poterucha J, Sanchez W, Watt K, Wiesner R, Charlton M. Noninvasive diagnosis of acute cellular rejection in liver transplant recipients: a proteomic signature validated by enzyme-linked immunosorbent assay. Liver Transpl. 2011 Jun; 17(6):723-32.
    View PubMed
  69. Heimbach JK, Sanchez W, Rosen CB, Gores GJ. Trans-peritoneal fine needle aspiration biopsy of hilar cholangiocarcinoma is associated with disease dissemination. HPB (Oxford). 2011 May; 13(5):356-60. Epub 2011 Mar 29.
    View PubMed
  70. Gali B, Plevak DJ, Nagorney DM, Rosen CB, Heimbach JK, Dierkhising RA, Findlay JY. Perioperative events in living and deceased donor liver transplant recipients: A case control study. Open Transplantation Journal. 2011; 5:8-14.
  71. Coss E, Watt KD, Pedersen R, Dierkhising R, Heimbach JK, Charlton MR. Predictors of cardiovascular events after liver transplantation: a role for pretransplant serum troponin levels. Liver Transpl. 2011 Jan; 17(1):23-31.
    View PubMed
  72. Charlton MR, Thompson A, Veldt BJ, Watt K, Tillmann H, Poterucha JJ, Heimbach JK, Goldstein D, McHutchison J. Interleukin-28B polymorphisms are associated with histological recurrence and treatment response following liver transplantation in patients with hepatitis C virus infection. Hepatology 2011 Jan; 53 (1):317-24
    View PubMed
  73. Mathur AK, Heimbach J, Steffick DE, Sonnenday CJ, Goodrich NP, Merion RM. Donation after cardiac death liver transplantation: predictors of outcome. Am J Transplant 2010 Nov; 10 (11):2512-9
    View PubMed
  74. Gores GJ, Heimbach JK, Rosen CB. Liver transplantation for non-hepatocellular carcinoma malignancies. Liver Transpl. 2010 Oct; 16(S2):S22-5.
    View PubMed
  75. Watt KD, Coss E, Pedersen RA, Dierkhising R, Heimbach JK, Charlton MR. Pretransplant serum troponin levels are highly predictive of patient and graft survival following liver transplantation. Liver Transpl. 2010 Aug; 16(8):990-8.
    View PubMed
  76. Rosen CB, Heimbach JK, Gores GJ. Liver transplantation for cholangiocarcinoma. Transpl Int. 2010 Jul; 23(7):692-7. Epub 2010 May 20.
    View PubMed
  77. Asrani SK, Lim YS, Therneau TM, Pedersen RA, Heimbach J, Kim WR. Donor race does not predict graft failure after liver transplantation. Gastroenterology 2010 Jun; 138 (7):2341-7 Epub 2010 Feb 19
    View PubMed
  78. Watt KD, Pedersen RA, Kremers WK, Heimbach JK, Charlton MR. Evolution of causes and risk factors for mortality post-liver transplant: results of the NIDDK long-term follow-up study. Am J Transplant 2010 Jun; 10 (6):1420-7 Epub 2010 May 10
    View PubMed
  79. Watt KD, Pedersen RA, Kremers WK, Heimbach JK, Sanchez W, Gores GJ. Long-term probability of and mortality from de novo malignancy after liver transplantation. Gastroenterology 2009 Dec; 137 (6):2010-7 Epub 2009 Sept 18
    View PubMed
  80. Veldt BJ, Poterucha JJ, Watt KD, Wiesner RH, Hay JE, Rosen CB, Heimbach JK, Janssen HL, Charlton MR. Insulin resistance, serum adipokines and risk of fibrosis progression in patients transplanted for hepatitis C. Am J Transplant. 2009 Jun; 9(6):1406-13. Epub 2009 May 13.
    View PubMed
  81. Rea DJ, Rosen CB, Nagorney DM, Heimbach JK, Gores GJ. Transplantation for cholangiocarcinoma: when and for whom? Surg Oncol Clin N Am. 2009 Apr; 18(2):325-37, ix.
    View PubMed
  82. Berg CL, Steffick DE, Edwards EB, Heimbach JK, Magee JC, Washburn WK, Mazariegos GV. Liver and intestine transplantation in the United States 1998-2007. Am J Transplant. 2009 Apr; 9(4 Pt 2):907-31.
    View PubMed
  83. Keegan MT, Gali B, Findlay JY, Heimbach JK, Plevak DJ, Afessa B. APACHE III outcome prediction in patients admitted to the intensive care unit after liver transplantation: a retrospective cohort study. BMC Surg. 2009; 9:11. Epub 2009 Jul 29.
    View PubMed
  84. Veldt BJ, Poterucha JJ, Watt KD, Wiesner RH, Hay JE, Kremers WK, Rosen CB, Heimbach JK, Charlton MR. Impact of pegylated interferon and ribavirin treatment on graft survival in liver transplant patients with recurrent hepatitis C infection. Am J Transplant 2008 Nov; 8 (11):2426-33 Epub 2008 Aug 22
    View PubMed
  85. Mathis KL, Dozois EJ, Larson DW, Cima RR, Sarmiento JM, Wolff BG, Heimbach JK, Pemberton JH. Ileal pouch-anal anastomosis and liver transplantation for ulcerative colitis complicated by primary sclerosing cholangitis. Br J Surg. 2008 Jul; 95(7):882-6.
    View PubMed
  86. Mathis KL, Dozois EJ, Larson DW, Cima RR, Sarmeinto JM, Wolff BG, Heimbach JK, Pemberton JH. Ileal pouch-anal anastomosis, liver transplantation for ulcerative colitis complicated by primary sclerosing cholangitis. Br J Surg. 2008 May 21.
  87. Heimbach JK. Successful liver transplantation for hilar cholangiocarcinoma. Curr Opin Gastroenterol. 2008 May; 24(3):384-8.
    View PubMed
  88. Leonard J, Heimbach JK, Malinchoc M, Watt K, Charlton M. The impact of obesity on long-term outcomes in liver transplant recipients-results of the NIDDK liver transplant database. Am J Transplant 2008 Mar; 8 (3):667-72
    View PubMed
  89. Heimbach JK. Liver transplantation for hepatocellular carcinoma. Cancer J. 2008 Mar-Apr; 14(2):95-9.
    View PubMed
  90. Rosen CB, Heimbach JK, Gores GJ. Surgery for cholangiocarcinoma: the role of liver transplantation. HPB (Oxford) 2008; 10 (3):186-9
    View PubMed
  91. Mantel HT, Rosen CB, Heimbach JK, Nyberg SL, Ishitani MB, Andrews JC, McKusick MA, Haddock MG, Alberts SR, Gores GJ. Vascular complications after orthotopic liver transplantation after neoadjuvant therapy for hilar cholangiocarcinoma. Liver Transpl. 2007 Oct; 13(10):1372-81.
    View PubMed
  92. Perri R, Assi M, Talwalkar J, Heimbach J, Hogan W, Moore SB, Rosen CB. Graft vs. host disease after liver transplantation: a new approach is needed. Liver Transpl. 2007 Aug; 13(8):1092-9.
    View PubMed
  93. Rosen CB, Heimbach JK, Gores GJ. Current status of liver transplantation for hilar cholangiocarcinoma. Curr Opin Organ Transplant 2007 Jun; 12 (3):215-219
    View PubMed
  94. Heimbach JK, Gores GJ, Haddock MG, Alberts SR, Pedersen R, Kremers W, Nyberg SL, Ishitani MB, Rosen CB. Predictors of disease recurrence following neoadjuvant chemoradiotherapy and liver transplantation for unresectable perihilar cholangiocarcinoma. Transplantation. 2006 Dec 27; 82(12):1703-7.
    View PubMed
  95. Rea DJ, Heimbach JK, Grande JP, Textor SC, Taler SJ, Prieto M, Larson TS, Cosio FG, Stegall MD. Glomerular volume and renal histology in obese and non-obese living kidney donors. Kidney Int. 2006 Nov; 70(9):1636-41. Epub 2006 Sep 06.
    View PubMed
  96. Heimbach JK, Gores GJ, Nagorney DM, Rosen CB. Liver transplantation for perihilar cholangiocarcinoma after aggressive neoadjuvant therapy: a new paradigm for liver and biliary malignancies? Surgery. 2006 Sep; 140(3):331-4.
    View PubMed
  97. Rea DJ, Heimbach JK, Rosen CB, Haddock MG, Alberts SR, Kremers WK, Gores GJ, Nagorney DM. Liver transplantation with neoadjuvant chemoradiation is more effective than resection for hilar cholangiocarcinoma. Ann Surg. 2005 Sep; 242(3):451-8; discussion 458-61.
    View PubMed
  98. Ishitani MB, Milliner DS, Kim DY, Bohorquez HE, Heimbach JK, Sheedy PF 2nd, Morgenstern BZ, Gloor JM, Murphy JG, McBane RD, Bielak LF, Peyser PA, Stegall MD. Early subclinical coronary artery calcification in young adults who were pediatric kidney transplant recipients. Am J Transplant 2005 Jul; 5 (7):1689-93
    View PubMed
  99. Heimbach JK, Taler SJ, Prieto M, Cosio FG, Textor SC, Kudva YC, Chow GK, Ishitani MB, Larson TS, Stegall MD. Obesity in living kidney donors: Clinical characteristics and outcomes in the era of laparoscopic donor nephrectomy. Am J Transplant. 2005 May; 5(5):1057-64.
    View PubMed
  100. Heimbach JK, Menon KVN, Ishitani MB, Nyberg SL, Jankowski CJ, Lindor KD, Rosen CB. Living donor liver transplantation using a right lobe graft in an adult with situs inversus. Liver Transpl. 2005 Jan; 11(1):111-3.
    View PubMed
  101. Kim DY, Stegall MD, Prieto M, Chow GK, Bohorquez HE, Covarrubias MA, Heimbach JK, Morgenstern BZ, Gloor JM, Milliner DS, Weckwerth JA, Weis KD, Ishitani MB. Hand-assisted laparoscopic donor nephrectomy for pediatric kidney allograft recipients. Pediatr Transplant. 2004 Oct; 8(5):460-3.
    View PubMed
  102. de la Vega LSP, Torres A, Bohorquez HE, Heimbach JK, Gloor JM, Schwab TR, Taler SJ, Nyberg SL, Ishitani MB, Prieto M, Velosa JA, Larson TS, Stegall MD, Cosio FG, Textor SC, Griffin MD. Patient and graft outcomes from older living kidney donors are similar to those from younger donors despite lower GFR. Kidney Int. 2004 Oct; 66(4):1654-61.
    View PubMed
  103. Heimbach JK, Haddock MG, Alberts SR, Nyberg SL, Ishitani MB, Rosen CB, Gores GJ. Transplantation for hilar cholangiocarcinoma. Liver Transpl. 2004 Oct; 10(10 Suppl 2):S65-8.
    View PubMed
  104. Heimbach JK, Gores GJ, Haddock MG, Alberts SR, Nyberg SL, Ishitani MB, Rosen CB. Liver transplantation for unresectable perihilar cholangiocarcinoma. Semin Liver Dis. 2004 May; 24(2):201-7.
    View PubMed
  105. Robinson TL Biffl WL, Moore EE, Heimbach JK, Calkins CM, Burch JM. Routine preoperative laboratory analyses are unnecessary before elective laparoscopic cholecystectomy. Surg Endoscopy. 2003 Mar; 17(3):438-41.
  106. Robinson TN, Biffl WL, Moore EE, Heimbach JK, Calkins CM, Burch JM. Predicting failure of outpatient laparoscopic cholecystectomy. Am J Surg. 2002 Dec; 184(6):515-8.
    View PubMed
  107. Calkins CM, Heimbach JK, Bensard DD, Song Y, Raeburn CD, Meng X, McIntyre RC. TNF receptor I mediates chemokine production and neutrophil accumulation in the lung following systemic lipopolysaccharide. J Surg Res. 2001 Dec; 101(2):232-7.
    View PubMed
  108. Heimbach JK, Reznikov LL, Calkins CM, Robinson TN, Dinarello CA, Harken AH, Meng X. TNF receptor I is required for induction of macrophage heat shock protein 70. Am J Physiol Cell Physiol. 2001 Jul; 281(1):C241-7.
    View PubMed
  109. Calkins, CM, Bensard DD, Heimbach JK, Meng X, Shames BD, Pulido EJ, McIntyre RC. L-arginine attenuates lipopolysaccharide-induced lung chemokine production. Am J Physiol Lung Cell Mol Physiol. 2001 Mar; 280(3):L400-8.
    View PubMed
  110. Robinson TR, Morrell TD, Pomerantz BJ, Heimbach JK, Cairns CB, Harken AH. Therapeutically accessible clinical cardiac states. J Am Coll Surg. 2000 Oct; 191(4):452-63.
    View PubMed
  111. Pomerantz, BJ, Robinson TN, Morrell TD, Heimbach JK, Banerjee A, Harken AH. Selective mitochondrial adenosine triphosphate-sensitive potassium channel activation is sufficient to precondition human myocardium. J Thorac Cardiovasc Surg. 2000 Aug; 120(2):387-92.
    View PubMed
  112. Pomerantz BJ, Robinson TN, Heimbach JK, Calkins CM, Miller SA, Banerjee A, Harken AH. Selective mitochondrial KATP channel opening controls human myocardial preconditioning: too much of a good thing? Surgery. 2000 Aug; 128(2):368-73.
    View PubMed
  113. Heimbach JK, Reznikov LL Calkins CM, Robinson TN, Dinarello CA, Harken AH, Meng X. Thermotolerance is Independent of Heat Shock Protein 70. Owen H. Wagensteen Surgical Forum. 2000; 51:48-9.
  114. Lacy MQ, Donovan KA, Heimbach JK, Ahmann GJ, Lust JA. Comparison of interleukin-1 beta expression by in situ hybridization in monoclonal gammopathy of undetermined significance and multiple myeloma. Blood. 1999 Jan 1; 93(1):300-5.
    View PubMed
  115. Heimbach JK, Mitchel E, Finlayson CA, Myers A, Franciose R, Rabinovich RA, Schwartzberg B, Biffl WL. Breast conservation therapy in affiliated county, private and university hospitals. American Journal of Surgery. 1999; 178(6):460-9.
    View PubMed
  116. Donovan KA, Lacy MQ, Kline MP, Ahmann GJ, Heimbach JK, Kyle RA, Lust JA. Contrast in cytokine expression between patients with monoclonal gammopathy of undetermined significance or multiple myeloma. Leukemia. 1998 Apr; 12(4):593-600.
    View PubMed